Imatinib Active Not Recruiting Phase 4 Trials for Chronic Myeloid Leukemia (CML) Other

IndicationsStatusPurposePhase
Active Not RecruitingOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT01578213Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients